发明名称 |
Composition and method of <i>Lactobacillus reuteri </i>GMNL-89 in treating type 2 diabetes |
摘要 |
Present invention features a novel use of Lactobacillus for treating type 2 diabetes, wherein the Lactobacillus is Lactobacillus reuteri GMNL-89 with the deposition numbers of BCRC 910340 and CCTCC M 207154 and comprises of live, dead bacteria or supernatant of the bacterial culture(s) and a pharmaceutically acceptable vehicle. The invention also discloses the efficacies of the indicated Lactobacillus strain including anti-oxidative enzyme activity, anti-inflammation, reduction of blood glucose level, reduction of triglycerides, reduction of total cholesterol, reduction of LDL, increase of HDL and improve insulin utilization. |
申请公布号 |
US9301983(B2) |
申请公布日期 |
2016.04.05 |
申请号 |
US201414200162 |
申请日期 |
2014.03.07 |
申请人 |
GenMont Biotech Inc. |
发明人 |
Huang Hui-Yu;Chen Yi-Hsing;Hsieh Feng-Ching |
分类号 |
A61K49/00;A01N63/00;C12N1/20;A61K35/747;A61K45/06;A23L1/30;A61K9/00 |
主分类号 |
A61K49/00 |
代理机构 |
WPAT, P.C. |
代理人 |
WPAT, P.C. ;King Anthony |
主权项 |
1. A method for treating type 2 diabetes and its complications, comprising administrating a probiotic composition, wherein the probiotic composition comprises supernatant of the live bacterial cultures of Lactobacillus reuteri GMNL-89 with the deposition number of CCTCC M 207154; wherein the live bacterial cultures are cultured at least 16 hours; wherein the supernatant is filtrated via filter membrane to filter out bacteria cells; the total protein of the administrating supernatant is adjusted to 20 μg/ml or 100 μg/m1; a daily dose of the administrating supernatant is 9.7 mL/day. |
地址 |
Tainan County TW |